Dr Elijah Nazarzadeh
Founder and Chief Scientific Officer

About

Elijah Nazarzadeh, PhD, is the Founder and Chief Scientific Officer of Acu-Flow Limited (trading as Nebu-Flow). Dr Nazarzadeh has a PhD in Fluid Mechanics from King’s College London (UK). During his career, he has provided scientific consultation to a number of companies in the field of colloids and interface science. He developed the Nebu~Flow technology while working as a postdoctoral researcher at the University of Glasgow (UK) and led its development and commercialisation activities, then founding Acu-Flow Limited in 2019. Dr Nazarzadeh received a Lee Lucas Award from the Institute of Physics (UK) for his exceptional efforts in the development of Nebu~Flow technology.

Contributions

PULMONARY

INNOVATIVE ACOUSTIC NEBULISER TECHNOLOGY

Andrea Cusack, Elijah Nazarzadeh and John Pritchard share insights into the company’s innovative nebuliser platform, designed to overcome the technical restrictions of current technologies that limit the delivery of advanced medicines to the lungs. They also share an update on the development of new digital features for the Nebu-Flow product range.

More contributions

EARLY INSIGHT

CREATING A PLATFORM FOR NEBULISATION OF A WIDE RANGE OF DRUG TYPES AND FORMULATIONS

Elijah Nazarzadeh and John Pritchard introduce Nebu~Flow – a novel class of nebuliser technology that represents a major step in the ability to deliver drugs efficiently to the lungs. overcoming the limitations of current systems and unlocking the potential of the inhalation route, including for systemic delivery.